Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 10, 2010
The application of sulforhodamine B as a colorimetric endpoint in a cytotoxicity assayS P FrickerMetal-Based Drugs|May 14, 2008
A Screening Strategy for Metal Antitumor Agents as Exemplified by Gold(III) ComplexesS P FrickerToxicology in Vitro : an International Journal Published in Association with BIBRA|August 10, 2010
A role for in vitro cytotoxicity testing in the selection and development of metal-based pharmaceutical and materials productsS P FrickerExpert Opinion on Investigational Drugs|July 5, 2005
Nitric oxide scavengers as a therapeutic approach to nitric oxide mediated diseaseS P FrickerAnticancer Research|November 1, 1996
Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agentsS P Fricker, R G BuckleyJournal of Inorganic Biochemistry|March 10, 2001
The in vitro antitumour profile of some 1,2-diaminocyclohexane organotin complexesJ J Bonire, S P FrickerAnticancer Research|May 5, 1999
Macrophage-derived superoxide is not required for nitric oxide mediated tumour cell killing by RAW 264 cellsS P Fricker, E Slade, N A PowellMetal-Based Drugs|January 1, 1995
Synthesis, Structure of Nitrogen-Containing Phosphinogold(I) Ferrocenes. In vitro Activity against Bladder and Colon Carcinoma Cell LinesM Viotte, B Gautheron, M M Kubicki, et al.Biochemical and Biophysical Research Communications|March 22, 2002
Mechanistic studies on AMD6221: a ruthenium-based nitric oxide scavengerR Mosi, B Seguin, B Cameron, et al.American Journal of Physiology. Renal Physiology|August 1, 2014
CXCR₄antagonism as a therapeutic approach to prevent acute kidney injuryA Zuk, M Gershenovich, Y Ivanova, et al.Pageof 2